Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $99,300 | 57 | 63.3% |
| Consulting Fee | $23,746 | 10 | 15.1% |
| Travel and Lodging | $21,004 | 83 | 13.4% |
| Food and Beverage | $7,961 | 133 | 5.1% |
| Honoraria | $4,475 | 4 | 2.9% |
| Entertainment | $188.50 | 1 | 0.1% |
| Education | $115.87 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Paratek Pharmaceuticals, Inc. | $61,318 | 91 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $51,716 | 83 | $0 (2023) |
| Melinta Therapeutics, LLC | $35,883 | 72 | $0 (2024) |
| The Medicines Company | $3,289 | 18 | $0 (2017) |
| Abbott Laboratories | $1,125 | 1 | $0 (2022) |
| Nabriva Therapeutics, plc | $1,102 | 2 | $0 (2020) |
| Quidel Corporation | $600.00 | 2 | $0 (2023) |
| Boston Scientific Corporation | $470.50 | 10 | $0 (2024) |
| MeMed US, Inc. | $417.40 | 3 | $0 (2024) |
| Medtronic Vascular, Inc. | $400.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,882 | 13 | Melinta Therapeutics, LLC ($5,906) |
| 2023 | $22,785 | 36 | Paratek Pharmaceuticals, Inc. ($15,188) |
| 2022 | $48,768 | 76 | Paratek Pharmaceuticals, Inc. ($21,461) |
| 2021 | $29,761 | 53 | AstraZeneca Pharmaceuticals LP ($20,034) |
| 2020 | $25,055 | 38 | Paratek Pharmaceuticals, Inc. ($13,061) |
| 2019 | $6,896 | 34 | Melinta Therapeutics, Inc. ($3,984) |
| 2018 | $9,955 | 21 | Melinta Therapeutics, Inc. ($5,201) |
| 2017 | $3,689 | 19 | The Medicines Company ($3,289) |
All Payment Transactions
290 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: ANTIBIOTIC | ||||||
| 09/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTIBIOTIC | ||||||
| 08/26/2024 | MeMed US, Inc. | MeMed BV Calibrator (Device) | Education | In-kind items and services | $103.87 | General |
| 08/15/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,505.00 | General |
| Category: ANTIBIOTIC | ||||||
| 08/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Travel and Lodging | Cash or cash equivalent | $36.18 | General |
| Category: ANTIBIOTIC | ||||||
| 08/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: ANTIBIOTIC | ||||||
| 08/09/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | Cash or cash equivalent | $8.20 | General |
| Category: ANTIBIOTIC | ||||||
| 05/01/2024 | MeMed US, Inc. | MeMed BV Calibrator (Device) | Food and Beverage | In-kind items and services | $125.03 | General |
| 05/01/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: ANTIBIOTIC | ||||||
| 02/22/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Consulting Fee | Cash or cash equivalent | $5,906.32 | General |
| Category: ANTIBIOTICS | ||||||
| 01/31/2024 | Boston Scientific Corporation | Axios (Device) | Food and Beverage | In-kind items and services | $98.08 | General |
| Category: Axios_ENDO | ||||||
| 01/18/2024 | MeMed US, Inc. | MeMed BV Calibrator (Device) | Entertainment | In-kind items and services | $188.50 | General |
| 01/18/2024 | Boston Scientific Corporation | Resolution 360 Clip (Device) | Food and Beverage | In-kind items and services | $43.29 | General |
| Category: Resolution 360 Clip_ENDO | ||||||
| 12/20/2023 | Medtronic, Inc. | NEXPOWDER (Device) | Food and Beverage | In-kind items and services | $136.24 | General |
| Category: Therapeutic Endoscopy | ||||||
| 12/06/2023 | Kyowa Kirin, Inc. | — | Food and Beverage | In-kind items and services | $139.79 | General |
| 10/25/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $138.68 | General |
| Category: ANTIBIOTICS | ||||||
| 10/25/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: ANTIBIOTICS | ||||||
| 08/23/2023 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $47.29 | General |
| 08/23/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: ANTIBIOTICS | ||||||
| 06/22/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: ANTIBIOTICS | ||||||
| 06/22/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTIBIOTICS | ||||||
| 06/22/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Travel and Lodging | Cash or cash equivalent | $5.90 | General |
| Category: ANTIBIOTICS | ||||||
| 06/21/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: ANTIBIOTICS | ||||||
| 06/21/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTIBIOTICS | ||||||
| 06/21/2023 | Melinta Therapeutics, LLC | Kimyrsa (Drug) | Travel and Lodging | Cash or cash equivalent | $5.90 | General |
| Category: ANTIBIOTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 158 | 160 | $264,143 | $19,067 |
| 2022 | 2 | 85 | 85 | $140,293 | $10,059 |
| 2021 | 2 | 116 | 116 | $194,948 | $14,587 |
| 2020 | 5 | 194 | 194 | $292,054 | $21,775 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 78 | 78 | $152,646 | $11,075 | 7.3% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 50 | 51 | $65,739 | $4,260 | 6.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 20 | $44,240 | $3,510 | 7.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 11 | 11 | $1,518 | $222.20 | 14.6% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 46 | 46 | $90,022 | $6,381 | 7.1% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 39 | 39 | $50,271 | $3,678 | 7.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 68 | 68 | $133,076 | $10,001 | 7.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 48 | 48 | $61,872 | $4,586 | 7.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 93 | 93 | $182,001 | $13,049 | 7.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 53 | 53 | $68,317 | $5,190 | 7.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 13 | 13 | $28,756 | $2,409 | 8.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 14 | 14 | $9,352 | $673.33 | 7.2% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2020 | 21 | 21 | $3,628 | $454.55 | 12.5% |
About Dr. David Robinson, M.D
Dr. David Robinson, M.D is a Emergency Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831115922.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Robinson, M.D has received a total of $156,790 in payments from pharmaceutical and medical device companies, with $9,882 received in 2024. These payments were reported across 290 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($99,300).
As a Medicare-enrolled provider, Robinson has provided services to 553 Medicare beneficiaries, totaling 555 services with total Medicare billing of $65,489. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Houston, TX
- Active Since 07/14/2006
- Last Updated 01/23/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1831115922
Products in Payments
- NUZYRA (Drug) $61,318
- LOKELMA (Drug) $51,139
- Kimyrsa (Drug) $26,596
- Orbactiv (Drug) $9,123
- MINOCIN IV (Drug) $2,932
- I-STAT (Device) $1,125
- Xenleta (Drug) $1,102
- MeMed BV Calibrator (Device) $417.40
- MyCareLink Smart (Device) $400.00
- ANDEXXA (Biological) $356.41
- ORBACTIV (Drug) $335.73
- NEXPOWDER (Device) $136.24
- Axios (Device) $98.08
- RESOLUTION CLIP (Device) $96.73
- Vabomere (Drug) $85.18
- EXALT (Device) $71.70
- GENERAL ENDOCHOICE (Device) $63.08
- SPYGLASS (Device) $54.89
- Baxdela (Drug) $50.76
- Resolution 360 Clip (Device) $43.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Houston
William Peacock, Md, MD
Emergency Medicine — Payments: $667,178
Dr. Zubaid Rafique, M.d, M.D
Emergency Medicine — Payments: $69,095
Yen-Te Tu, M.d, M.D
Emergency Medicine — Payments: $60,443
Dr. Kelly Larkin, M.d, M.D
Emergency Medicine — Payments: $57,511
Robert Dickson, Md, MD
Emergency Medicine — Payments: $51,039
Dr. Kumar Alagappan, Md, MD
Emergency Medicine — Payments: $44,227